Gestational Diabetes mellitus
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.author | Hajhoseini Aliabadi, Fereshte | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.opponentdept | Kenézy Kórházy Központi Aneszteziológiai és Intenzív Terápiás Osztály | hu_HU |
dc.date.accessioned | 2018-08-02T11:19:37Z | |
dc.date.available | 2018-08-02T11:19:37Z | |
dc.date.created | 2017 | |
dc.description.abstract | GDM is a transient diabetes mellitus (with inadequate insulin secretion and poor response), during pregnancy with no previous diagnosis of DM. GDM is a fully treatable condition and the management is very important to reduce adverse outcomes for mother and baby. The diagnosis of GDM is in the 24-28 weeks of pregnancy,if the diet and physical activity couldn’t keep the target glucose level then medications should be add. There is human insulin( NPH and regular )which preferred in pregnancy and also analogue insulins like lispro and novorapid can be use.insulin is safe for fetus and should be initiate if necessary. | hu_HU |
dc.description.corrector | hbk | |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 41 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/255921 | |
dc.language.iso | en | hu_HU |
dc.subject | pharmacology | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
dc.title | Gestational Diabetes mellitus | hu_HU |